These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Chemical modification of tazobactam. Synthesis of 2 beta-[(4-substituted)-1,2,3-triazol-1-yl]methyl penicillanic acid sulfone derivatives. Setti EL; Fiakpui C; Phillips OA; Czajkowski DP; Atchison K; Micetich RG; Maiti SN; Kunugita C; Hyodo A J Antibiot (Tokyo); 1995 Nov; 48(11):1320-9. PubMed ID: 8557575 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 2 beta-oxyimino and alkenylpenicillanic acid sulfone derivatives as beta-lactamase inhibitors. Cho YS; Ha YJ; Kwon JS; Pae AN; Choi KI; Koh HY; Chang MH; Yoon CM; Lee GS Arch Pharm (Weinheim); 1999 Jan; 332(1):7-12. PubMed ID: 10073138 [TBL] [Abstract][Full Text] [Related]
7. Allyl and propargyl substituted penam sulfones as versatile intermediates toward the syntheses of new beta-lactamase inhibitors. Sandanayaka VP; Feigelson GB; Prashad AS; Yang Y; Petersen PJ Bioorg Med Chem Lett; 2001 Apr; 11(8):997-1000. PubMed ID: 11327608 [TBL] [Abstract][Full Text] [Related]
8. Comparative in-vitro activities of GD-40 and other beta-lactamase inhibitors against TEM-1 and SHV-2 beta-lactamases. Danelon G; Mascaretti O; Radice M; Power P; Calcagno ML; Mata EG; Gutkind G J Antimicrob Chemother; 1998 Feb; 41(2):313-5. PubMed ID: 9533481 [No Abstract] [Full Text] [Related]
9. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases. Bonomo RA; Rudin SA; Shlaes DM FEMS Microbiol Lett; 1997 Mar; 148(1):59-62. PubMed ID: 9066111 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of beta-lactamases by 6,6-bis(hydroxylmethyl)penicillanate. Nagase T; Golemi D; Ishiwata A; Mobashery S Bioorg Chem; 2001 Jun; 29(3):140-5. PubMed ID: 11437389 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and crystal structures of 6-alkylidene-2'-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase. Bou G; Santillana E; Sheri A; Beceiro A; Sampson JM; Kalp M; Bethel CR; Distler AM; Drawz SM; Pagadala SR; van den Akker F; Bonomo RA; Romero A; Buynak JD J Am Chem Soc; 2010 Sep; 132(38):13320-31. PubMed ID: 20822105 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and beta-lactamase inhibitory activity of 6-fluoropenicillanic acids. Danelon GO; Laborde M; Mascaretti OA; Boggio SB; Roveri OA Bioorg Med Chem; 1993 Dec; 1(6):447-55. PubMed ID: 8087566 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of some heterofunctionalized penicillanic acid derivatives and investigation of their biological activities. Demirci S; Demirbas A; Ulker S; Alpay-Karaoglu S; Demirbas N Arch Pharm (Weinheim); 2014 Mar; 347(3):200-20. PubMed ID: 24293403 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and beta-lactamase inhibitory activity of 6-[(1-heteroarylthioethyl-1,2,3-triazol-4-yl)-methylene]penam sulfones. Im C; Maiti SN; Micetich RG; Daneshtalab M; Atchison K; Phillips OA; Kunugita C J Antibiot (Tokyo); 1994 Sep; 47(9):1030-40. PubMed ID: 7928691 [TBL] [Abstract][Full Text] [Related]
15. [Beta-lactamase inhibitors. I. Synthesis and biological properties of penicillanic acid derivatives]. Mikołajczyk J; Kotulowa W; Kazimierczak J; Sikora A; Rogowska W; Cieślak J Acta Pol Pharm; 1980; 37(6):637-41. PubMed ID: 6270960 [No Abstract] [Full Text] [Related]
16. Synthesis of new sulfonylamido-penicillanic acid sulfones inhibitors of beta-lactamases. Vanwetswinkel S; Fastrez J; Marchand-Brynaert J J Antibiot (Tokyo); 1994 Sep; 47(9):1041-51. PubMed ID: 7928692 [TBL] [Abstract][Full Text] [Related]
17. Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors. Sandanayaka VP; Prashad AS Curr Med Chem; 2002 Jun; 9(12):1145-65. PubMed ID: 12052169 [TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be. Tzouvelekis LS; Gazouli M; Prinarakis EE; Tzelepi E; Legakis NJ Antimicrob Agents Chemother; 1997 Feb; 41(2):475-7. PubMed ID: 9021212 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of inhibition of the carbenicillin-hydrolyzing beta-lactamase PSE-4 by the clinically used mechanism-based inhibitors. Therrien C; Kotra LP; Sanschagrin F; Mobashery S; Levesque RC FEBS Lett; 2000 Mar; 470(3):285-92. PubMed ID: 10745083 [TBL] [Abstract][Full Text] [Related]
20. The synthesis and evaluation of 2-substituted-7-(alkylidene)cephalosporin sulfones as beta-lactamase inhibitors. Buynak JD; Doppalapudi VR; Rao AS; Nidamarthy SD; Adam G Bioorg Med Chem Lett; 2000 May; 10(9):847-51. PubMed ID: 10853645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]